Cite

    Xinglu Chen et al.. “Norcantharidin counteracts acquired everolimus resistance in renal cell carcinoma by dual inhibition of mammalian target of rapamycin complex 1 and complex 2 pathways in Vitro.” Anti-cancer drugs, vol. 33, no. 1, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100178521416.0x000015